VRAX
Virax Biolabs Group Limited Ordinary Shares
NASDAQ: VRAX · HEALTHCARE · BIOTECHNOLOGY
$0.13
-0.81% today
Updated 2026-04-30
Market cap
$993260.00
P/E ratio
—
P/S ratio
332.64x
EPS (TTM)
$-1.22
Dividend yield
—
52W range
$0 – $1
Volume
15.9M
Virax Biolabs Group Limited Ordinary Shares (VRAX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-160,788.00%
ROE
-83.80%
ROA
-48.40%
Debt/equity
0.10x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $99876.00 | $-801131.00 | 45.81% | -652.05% | -802.13% |
| 2021 | $123820.00 | $-650984.00 | -7.62% | -520.55% | -525.75% |
| 2022 | $0.00 | $-1.71M | — | — | — |
| 2023 | $8561.00 | $-5.46M | -15.94% | -66,963.67% | -63,748.32% |
| 2024 | $156419.00 | $-6.73M | 32.34% | -4,153.25% | -4,304.81% |
| 2025 | $6331.00 | $-6.06M | -838.21% | -97,344.76% | -95,739.17% |